MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution.

Aneuploidy Cancer evolution Chromosomal instability Intratumor heterogeneity Phylogenetic reconstruction Single-cell sequencing Somatic copy-number alterations Whole-genome doubling

Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
14 11 2022
Historique:
received: 15 11 2021
accepted: 12 10 2022
entrez: 15 11 2022
pubmed: 16 11 2022
medline: 18 11 2022
Statut: epublish

Résumé

Aneuploidy, chromosomal instability, somatic copy-number alterations, and whole-genome doubling (WGD) play key roles in cancer evolution and provide information for the complex task of phylogenetic inference. We present MEDICC2, a method for inferring evolutionary trees and WGD using haplotype-specific somatic copy-number alterations from single-cell or bulk data. MEDICC2 eschews simplifications such as the infinite sites assumption, allowing multiple mutations and parallel evolution, and does not treat adjacent loci as independent, allowing overlapping copy-number events. Using simulations and multiple data types from 2780 tumors, we use MEDICC2 to demonstrate accurate inference of phylogenies, clonal and subclonal WGD, and ancestral copy-number states.

Identifiants

pubmed: 36376909
doi: 10.1186/s13059-022-02794-9
pii: 10.1186/s13059-022-02794-9
pmc: PMC9661799
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241

Subventions

Organisme : Cancer Research UK
ID : FC001169
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001202
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001169
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001202
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001169
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001202
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L016311/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep. 2012;13:528–38.
Sansregret L, Vanhaesebroeck B, Swanton C. Determinants and clinical implications of chromosomal instability in cancer. Nat Rev Clin Oncol. 2018;15:139–50.
Watkins TBK, Lim EL, Petkovic M, Elizalde S, Birkbak NJ, Wilson GA, et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature. 2020; Available from: https://doi.org/10.1038/s41586-020-2698-6 .
Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, et al. Tracking the evolution of non–small-cell lung cancer. N Engl J Med. 2017;376:2109–21.
Lee AJX, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 2011;71:1858–70.
Schwarz RF, Trinh A, Sipos B, Brenton JD, Goldman N, Markowetz F. Phylogenetic quantification of intra-tumour heterogeneity. PLoS Comput Biol. 2014;10:e1003535.
Schwarz RF, Ng CKY, Cooke SL, Newman S, Temple J, Piskorz AM, et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med. 2015;12:e1001789.
Beerenwinkel N, Schwarz RF, Gerstung M, Markowetz F. Cancer evolution: mathematical models and computational inference. Syst Biol. 2015;64:e1–25.
Watkins TBK, Schwarz RF. Phylogenetic quantification of intratumor heterogeneity. In: Bardelli A, Maley C, Polyak N, Yang Z, Swanton C, editors. Cancer Evolution. 2018.
Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413–21.
Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013;45:1134–40.
Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet. 2018;50:1189–95.
Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell. 2018;33:676–89.e3.
Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus. Proc Natl Acad Sci U S A. 1996;93:7081–4.
Imkie M, Davis MK, Persons DL, Cunningham MT. Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation. Arch Pathol Lab Med. 2004;128:448–51.
Watanabe A, Inokuchi K, Yamaguchi H, Mizuki T, Tanosaki S, Shimada T, et al. Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene. Clin Lab Haematol. 2004;26:25–30.
Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature. 2005;437:1043–7.
Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A, et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis. 2006;27:337–43.
Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460:278–82.
Dewhurst SM, McGranahan N, Burrell RA, Rowan AJ, Grönroos E, Endesfelder D, et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 2014;4:175–85.
López S, Lim EL, Horswell S, Haase K, Huebner A, Dietzen M, et al. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat Genet. 2020;52:283–93.
Marquis C, Fonseca CL, Queen KA, Wood L, Vandal SE, Malaby HLH, et al. Chromosomally unstable tumor cells specifically require KIF18A for proliferation. bioRxiv. 2020. p. 2020.06.18.159327. [cited 2021 Feb 21] Available from: https://www.biorxiv.org/content/10.1101/2020.06.18.159327v2
Quinton RJ, DiDomizio A, Vittoria MA, Kotýnková K, Ticas CJ, Patel S, et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature. 2021;590:492–7.
Cohen-Sharir Y, McFarland JM, Abdusamad M, Marquis C, Bernhard SV, Kazachkova M, et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature. 2021;590:486–91.
Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell. 2021;184:2239–54.e39.
Letouzé E, Allory Y, Bollet MA, Radvanyi F, Guyon F. Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis. Genome Biol. 2010;11:R76.
Satas G, Zaccaria S, Mon G, Raphael BJ. SCARLET: Single-cell tumor phylogeny inference with copy-number constrained mutation losses. Cell Syst. 2020;10:323–32.e8.
Wang F, Wang Q, Mohanty V, Liang S, Dou J, Han J, et al. MEDALT: single-cell copy number lineage tracing enabling gene discovery. Genome Biol. 2021;22:70.
Markowska M, Cąkała T, Miasojedow B, Juraeva D, Mazur J, Ross E, et al. CONET: copy number event tree model of evolutionary tumor history for single-cell data. bioRxiv. 2021;2021.04.23.441204.
Kimura M. The number of heterozygous nucleotide sites maintained in a finite population due to steady flux of mutations. Genetics. 1969;61:893–903.
Gao R, Davis A, McDonald TO, Sei E, Shi X, Wang Y, et al. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet. 2016;48:1119–30.
Martelotto LG, Baslan T, Kendall J, Geyer FC, Burke KA, Spraggon L, et al. Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples. Nat Med. 2017;23:376–85.
Zeira R, Zehavi M, Shamir R. A linear-time algorithm for the copy number transformation problem. J Comput Biol. 2017;24:1179–94.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578:82–93.
Mohri M, Pereira F, Riley M. Weighted finite-state transducers in speech recognition. Comput Speech Lang. 2002;16:69–88.
Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406–25.
Desper R, Gascuel O. Fast and accurate phylogeny reconstruction algorithms based on the minimum-evolution principle. J Comput Biol. 2002;9:687–705.
Salehi S, Dorri F, Chern K, Kabeer F, Rusk N, Funnell T, et al. Cancer phylogenetic tree inference at scale from 1000s of single cell genomes. bioRxiv. 2021. p. 2020.05.06.058180. [cited 2022 Jun 4] Available from: https://www.biorxiv.org/content/10.1101/2020.05.06.058180v2
Sapin E, Keller MC. Novel approach for parallelizing pairwise comparison problems as applied to detecting segments identical by decent in whole-genome data. Bioinformatics. 2021; [cited 2021 Apr 14] Available from: https://doi.org/10.1093/bioinformatics/btab084
Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JMC, Papaemmanuil E, et al. The evolutionary history of lethal metastatic prostate cancer. Nature. 2015;520:353–7.
Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, Park PJ, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell. 2013;155:948–62.
Martínez-Jiménez F, Movasati A, Brunner S, Nguyen L, Priestley P, Cuppen E, et al. Pan-cancer whole genome comparison of primary and metastatic solid tumors. bioRxiv. 2022. p. 2022.06.17.496528. [cited 2022 Jun 28] Available from: https://www.biorxiv.org/content/10.1101/2022.06.17.496528v1
Bakhoum SF, Ngo B, Laughney AM, Cavallo J-A, Murphy CJ, Ly P, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467–72.
Zaccaria S, Raphael BJ. Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data. Nat Commun. 2020;11:4301.
Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, et al. Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal. Cell. 2018;173:595–610.e11.
Minussi DC, Nicholson MD, Ye H, Davis A, Wang K, Baker T, et al. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature. 2021;592:302–8.
Kuipers J, Jahn K, Raphael BJ, Beerenwinkel N. Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors. Genome Res. 2017;27:1885–94.
Demeulemeester J, Dentro SC, Gerstung M, Van Loo P. Biallelic mutations in cancer genomes reveal local mutational determinants. Nat Genet. 2022;54:128–33.
Deshwar AG, Vembu S, Yung CK, Jang GH, Stein L, Morris Q. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 2015;16:35.
Foulds LR, Graham RL. The steiner problem in phylogeny is NP-complete. Adv Appl Math. 1982;3:43–9.
Cheng J, Demeulemeester J, Wedge DC, Vollan HKM, Pitt JJ, Russnes HG, et al. Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. Nat Commun. 2017;8:1221.
Davoli T, Denchi EL, de Lange T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell. 2010;141:81–93.
Elhajouji A, Cunha M, Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis. 1998;13:193–8.
Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature. 2005;437:1038–42.
Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, et al. Model for the genetic evolution of human solid tumors. Cancer Res. 1989;49:3344–54.
Steele CD, Tarabichi M, Oukrif D, Webster AP, Ye H, Fittall M, et al. Undifferentiated sarcomas develop through distinct evolutionary pathways. Cancer Cell. 2019;35:441–56.e8.
van den Bos H, Bakker B, Spierings DCJ, Lansdorp PM, Foijer F. Single-cell sequencing to quantify genomic integrity in cancer. Int J Biochem Cell Biol. 2018;94:146–50.
Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature. 2011;472:90–4.
Zaccaria S, Raphael BJ. Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL. Nat Biotechnol. 2021;39:207–14.
Kuipers J, Tuncel MA, Ferreira P, Jahn K, Beerenwinkel N. Single-cell copy number calling and event history reconstruction. bioRxiv. 2020. p. 2020.04.28.065755. [cited 2021 Jul 28] Available from: https://www.biorxiv.org/content/10.1101/2020.04.28.065755v1.full
Laughney AM, Elizalde S, Genovese G, Bakhoum SF. Dynamics of tumor heterogeneity derived from clonal karyotypic evolution. Cell Rep. 2015;12:809–20.
Elizalde S, Laughney AM, Bakhoum SF. A Markov chain for numerical chromosomal instability in clonally expanding populations. PLoS Comput Biol. 2018;14:e1006447.
Mohri M. Weighted Automata Algorithms. In: Droste M, Kuich W, Vogler H, editors. Handbook of Weighted Automata. Berlin, Heidelberg: Springer Berlin Heidelberg; 2009. p. 213–54.
Cortes C, Haffner P, Mohri M. Rational kernels: theory and algorithms. J Mach Learn Res. 2004;5:1035–62.
Schwarz RF, Fletcher W, Förster F, Merget B, Wolf M, Schultz J, et al. Evolutionary distances in the twilight zone—a rational kernel approach. PLoS One. Public Library of. Science. 2010;5:e15788.
Allauzen C, Riley M, Schalkwyk J, Skut W, Mohri M. OpenFst: a general and efficient weighted finite-state transducer library. Implementation and Application of Automata. Springer Berlin Heidelberg; 2007. p. 11–23.
Schwarz RF, Watkins TBK, Van Loo P. Accurate phasing of allele-specific copy-numbers for inferring tumour evolution with probe-level resolution. ISMB Late Breaking Research. 2015. Available from: https://www.youtube.com/watch?v=-ThcPI5M8gc&t=996s
Smith MR. Information theoretic generalized Robinson–Foulds metrics for comparing phylogenetic trees. Bioinformatics. academic.oup.com; 2020; Available from: https://academic.oup.com/bioinformatics/article-abstract/36/20/5007/5866976
Paradis E, Schliep K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics. 2019:526–8 Available from: https://doi.org/10.1093/bioinformatics/bty633 .
Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985;39:783–91.
Delsuc F, Brinkmann H, Philippe H. Phylogenomics and the reconstruction of the tree of life. Nat Rev Genet. 2005;6:361–75.
Lin Y, Rajan V, Moret BME. Bootstrapping phylogenies inferred from rearrangement data. Algorithms Mol Biol. 2012;7:21.
Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979–93.
Kaufmann TL, Petkovic M, Laskina S, Schwarz RF. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Bitbucket. 2022; Available from: https://bitbucket.org/schwarzlab/medicc2 .
Kaufmann TL, Petkovic M, Watkins TBK, Colliver EC, Laskina S, Thapa N, et al. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Zenodo. 2022; Available from: https://doi.org/10.5281/zenodo.7300106 .

Auteurs

Tom L Kaufmann (TL)

Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125, Berlin, Germany. tom.kaufmann@mdc-berlin.de.
Department of Electrical Engineering & Computer Science, Technische Universität Berlin, Marchstr. 23, 10587, Berlin, Germany. tom.kaufmann@mdc-berlin.de.
BIFOLD, Berlin Institute for the Foundations of Learning and Data, Berlin, Germany. tom.kaufmann@mdc-berlin.de.

Marina Petkovic (M)

Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Department of Biology, Humboldt University of Berlin, Unter den Linden 6, 10099, Berlin, Germany.
Division of Oncology and Hematology, Department of Pediatrics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Thomas B K Watkins (TBK)

The Francis Crick Institute, London, UK.

Emma C Colliver (EC)

The Francis Crick Institute, London, UK.

Sofya Laskina (S)

Department of Mathematics and Computer Science, Free University of Berlin, Berlin, Germany.

Nisha Thapa (N)

UCL Medical School, University College London, London, UK.

Darlan C Minussi (DC)

Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Nicholas Navin (N)

Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Charles Swanton (C)

The Francis Crick Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Department of Medical Oncology, University College London Hospitals, London, UK.

Peter Van Loo (P)

The Francis Crick Institute, London, UK.
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Kerstin Haase (K)

Division of Oncology and Hematology, Department of Pediatrics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Maxime Tarabichi (M)

The Francis Crick Institute, London, UK.
Institute for Interdisciplinary Research, Université Libre de Bruxelles, Brussels, Belgium.

Roland F Schwarz (RF)

Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125, Berlin, Germany. roland.schwarz@uni-koeln.de.
BIFOLD, Berlin Institute for the Foundations of Learning and Data, Berlin, Germany. roland.schwarz@uni-koeln.de.
Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO) and Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. roland.schwarz@uni-koeln.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH